Literature DB >> 16854054

Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.

Christy Rani R Grace1, Judit Erchegyi, Steven C Koerber, Jean Claude Reubi, Jean Rivier, Roland Riek.   

Abstract

The 3D NMR structures of six octapeptide agonist analogues of somatostatin (SRIF) in the free form are described. These analogues, with the basic sequence H-DPhe/Phe2-c[Cys3-Xxx7-DTrp8-Lys9-Thr10-Cys14]-Thr-NH2 (the numbering refers to the position in native SRIF), with Xxx7 being Ala/Aph, exhibit potent and highly selective binding to human SRIF type 2 (sst2) receptors. The backbone of these sst2-selective analogues have the usual type-II' beta-turn reported in the literature for sst2/3/5-subtype-selective analogues. Correlating the biological results and NMR studies led to the identification of the side chains of DPhe2, DTrp8, and Lys9 as the necessary components of the sst2 pharmacophore. This is the first study to show that the aromatic ring at position 7 (Phe7) is not critical for sst2 binding and that it plays an important role in sst3 and sst5 binding. This pharmacophore is, therefore, different from that proposed by others for sst2/3/5 analogues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854054      PMCID: PMC2515173          DOI: 10.1021/jm060363v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  45 in total

1.  Biologic and immunologic activities and applications of somatostatin analogs.

Authors:  W Vale; J Rivier; N Ling; M Brown
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

2.  Efficient analysis of protein 2D NMR spectra using the software package EASY.

Authors:  C Eccles; P Güntert; M Billeter; K Wüthrich
Journal:  J Biomol NMR       Date:  1991-07       Impact factor: 2.835

3.  Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.

Authors:  Christy Rani R Grace; Lukas Durrer; Steven C Koerber; Judit Erchegyi; Jean Claude Reubi; Jean E Rivier; Roland Riek
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

4.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

5.  A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis.

Authors:  C Gilon; M Huenges; B Mathä; G Gellerman; V Hornik; M Afargan; O Amitay; O Ziv; E Feller; A Gamliel; D Shohat; M Wanger; O Arad; H Kessler
Journal:  J Med Chem       Date:  1998-03-12       Impact factor: 7.446

6.  Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.

Authors:  Jean Rivier; Judit Erchegyi; Carl Hoeger; Charleen Miller; William Low; Sandra Wenger; Beatrice Waser; Jean-Claude Schaer; Jean Claude Reubi
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

7.  Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.

Authors:  Christy Rani R Grace; Steven C Koerber; Judit Erchegyi; Jean Claude Reubi; Jean Rivier; Roland Riek
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

8.  Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.

Authors:  Vidya Prasad; Elizabeth T Birzin; Cheryl T McVaugh; Rachel D Van Rijn; Susan P Rohrer; Gary Chicchi; Dennis J Underwood; Edward R Thornton; Amos B Smith; Ralph Hirschmann
Journal:  J Med Chem       Date:  2003-05-08       Impact factor: 7.446

Review 9.  Pharmacology of thyrotropin releasing factor (TRF), luteinizing hormone releasing factor (LRF), and somatostatin.

Authors:  W Vale; C Rivier; M Brown; J Rivier
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

10.  Structure of octreotide, a somatostatin analogue.

Authors:  E Pohl; A Heine; G M Sheldrick; Z Dauter; K S Wilson; J Kallen; W Huber; P J Pfäffli
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1995-01-01
View more
  22 in total

1.  Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.

Authors:  Andreas Stengel; Miriam Goebel-Stengel; Lixin Wang; Almaas Shaikh; Nils W G Lambrecht; Jean Rivier; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

2.  Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats.

Authors:  A Stengel; M Goebel-Stengel; L Wang; A Luckey; E Hu; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-05-13       Impact factor: 3.598

3.  Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice.

Authors:  A Stengel; M Goebel-Stengel; L Wang; M Larauche; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-06       Impact factor: 3.598

4.  Selective central activation of somatostatin receptor 2 increases food intake, grooming behavior and rectal temperature in rats.

Authors:  A Stengel; M Goebel; L Wang; J Rivier; P Kobelt; H Monnikes; Y Tache
Journal:  J Physiol Pharmacol       Date:  2010-08       Impact factor: 3.011

5.  In vitro structure-activity relationship of Re-cyclized octreotide analogues.

Authors:  Shorouk F Dannoon; Heather M Bigott-Hennkens; Lixin Ma; Fabio Gallazzi; Michael R Lewis; Silvia S Jurisson
Journal:  Nucl Med Biol       Date:  2010-07       Impact factor: 2.408

6.  Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.

Authors:  Agata Mulak; Muriel Larauche; Mandy Biraud; Mulugeta Million; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2014-11-05       Impact factor: 3.750

7.  Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.

Authors:  Judit Erchegyi; Renzo Cescato; Christy Rani R Grace; Beatrice Waser; Véronique Piccand; Daniel Hoyer; Roland Riek; Jean E Rivier; Jean Claude Reubi
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

Review 8.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

9.  Brain somatostatin receptor 2 mediates the dipsogenic effect of central somatostatin and cortistatin in rats: role in drinking behavior.

Authors:  Hiroshi Karasawa; Seiichi Yakabi; Lixin Wang; Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-16       Impact factor: 3.619

10.  Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity.

Authors:  Christy Rani R Grace; Judit Erchegyi; Manoj Samant; Renzo Cescato; Veronique Piccand; Roland Riek; Jean Claude Reubi; Jean E Rivier
Journal:  J Med Chem       Date:  2008-04-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.